Revision history of "Genomescale CRISPRa verification determines MTX1 as a bestower pertaining to sorafenib level of resistance throughout hepatocellular carcinoma by simply enhancing autophagy"

From EECH Central
Jump to: navigation, search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • (cur | prev) 10:37, 8 May 2024‎ Sarahcollar7 (Talk | contribs)‎ . . (3,496 bytes) (+3,496)‎ . . (Created page with "Epidermis considerably improved the chance of CKD (altered risk proportion 2.Forty-eight, 95% self confidence period One.81-3.45), so did hyperlipidemia (adjusted hazard ratio...")
Retrieved from "http://eechcentral.simhq.com/index.php?title=Genomescale_CRISPRa_verification_determines_MTX1_as_a_bestower_pertaining_to_sorafenib_level_of_resistance_throughout_hepatocellular_carcinoma_by_simply_enhancing_autophagy"